News | February 25, 2009

RTOG Elects Full Member Principal Investigators Chair

February 25, 2009 – The Radiation Therapy Oncology Group (RTOG) has elected Elizabeth M. Gore, M.D. chair of the Full Member Principal Investigators Committee.

Dr. Gore is the RTOG principal investigator for the Medical College of Wisconsin in Milwaukee, where she is an associate professor of radiation oncology. RTOG is a National Cancer Institute-funded national clinical trials group and is administered by the American College of Radiology.

“Dr. Gore is the principal investigator for one our most productive member institutions. She has been very active in RTOG research as a protocol chair and a member of our Lung Cancer Committee,” said Walter J. Curran, Jr., M.D., the RTOG Group Chair, and the Lawrence W. Davis Professor and Chair of the Department of Radiation Oncology in the Emory School of Medicine and Chief Medical Officer of the Emory Winship Cancer Institute. “She has made significant contributions to the group’s research mission and, in recognition of her commitment, the RTOG leadership named Dr. Gore to our inaugural class of RTOG Next Generation Investigators last spring.”

“I am honored to be elected by my fellow full member principal investigators to this position,” said Dr. Gore. “The full member institutions are the backbone of the group, helping to define its scientific mission and responsible for the majority of its accrual. I plan to work closely with the RTOG leadership, the Membership Committee, and headquarters’ staff to address our concerns about accrual, data submission, and reimbursement issues. Our goal is to help the full members improve their RTOG experience which will hopefully translate into increased accrual enhancing the group’s ability to complete protocols quickly.”

As the chair of the RTOG Full Member Principal Investigators Committee, Dr. Gore will serve on the RTOG Executive and Steering Committees representing the interests of the full member institutions and she will also chair the RTOG Bylaws Committee. Dr. Gore is the first investigator elected to this newly created position.

The Medical College of Wisconsin has been an RTOG member for over 30 years. In addition to her research and teaching responsibilities, Dr. Gore practices at the Zablocki VA Medical Center –Milwaukee, a major hospital affiliate of the College.

Source: The Radiation Therapy Oncology Group (RTOG) and the American College of Radiology (ACR)

For more information:

Related Content

New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Lung Decision Precision
News | Lung Cancer | June 04, 2018
For smokers and former smokers, the threat of lung cancer always lurks in the shadows.
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
Overlay Init